Kala Pharmaceuticals, Inc. (KALA) Social Stream
KALA PHARMACEUTICALS INC (KALA) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering KALA PHARMACEUTICALS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-29 | 7 | $43 | $3.75 | $14.458 | $3.88 | 272.63% |
| 2021-11-16 | 7 | $16 | $2.5 | $7.75 | $3.88 | 99.74% |
| 2021-12-15 | 7 | $9 | $2.5 | $6.083 | $3.88 | 56.78% |
| 2022-03-09 | 7 | $9 | $2.5 | $5.916 | $3.88 | 52.47% |
| 2022-03-30 | 7 | $9 | $2.5 | $5.916 | $3.88 | 52.47% |
| 2022-05-16 | 7 | $6 | $1.75 | $4.458 | $3.88 | 14.9% |
| 2022-05-17 | 7 | $6 | $1.75 | $3.958 | $3.88 | 2.01% |
| 2022-05-23 | 7 | $5 | $1.75 | $3.791 | $3.88 | -2.29% |
| 2022-05-24 | 7 | $4 | $1.75 | $3.125 | $3.88 | -19.46% |
| 2022-08-12 | 3 | $4 | $1.75 | $2.95 | $3.88 | -23.97% |
| 2022-08-15 | 3 | $4 | $1.75 | $2.65 | $3.88 | -31.7% |
| 2022-11-10 | 3 | $100 | $12 | $61.625 | $3.88 | 1488.27% |
| 2022-12-06 | 3 | $87.5 | $12 | $45.875 | $3.88 | 1082.35% |
KALA reports an average of 1,923.83% for its upside potential over the past 44 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-05-04 | 7 | 6.0 | 1.75 | 4.458 | 0.740 | 502.43% |
| 2022-05-24 | 7 | 4.0 | 1.75 | 2.950 | 0.475 | 521.05% |
| 2022-08-12 | 3 | 4.0 | 1.75 | 2.950 | 0.336 | 777.98% |
| 2022-11-10 | 3 | 100.0 | 12.00 | 61.625 | 6.580 | 836.55% |
| 2022-12-06 | 3 | 87.5 | 12.00 | 45.875 | 4.910 | 834.32% |
KALA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 3 | 0 | 0 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
KALA's average broker recommendation rating improved by 0.86 over the prior 52 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, KALA PHARMACEUTICALS INC's average analyst price target is greater than 242.09% of them.
- In the context of Pharmaceutical Products stocks, KALA PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 479.1% of them.
- To contextualize these metrics, consider that out of stocks in the small market cap category, KALA PHARMACEUTICALS INC's variance in analysts' estimates is lower than -1317.7% of them.
- In the context of stocks in the small market cap category, KALA PHARMACEUTICALS INC's number of analysts covering the stock is greater than 1064.47% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to KALA PHARMACEUTICALS INC are ATHE, VRNA, and URGN.
View All Top Stocks by Price Target
Make investment decisions regarding KALA using the data that counts. Try POWR Ratings for free.